IFI-M · UA Flux-Balanced Series

Specimen SS-F-M2-05551 // MULTI-AXIS · IFI-M

UA Flux-Balanced Series III-PR-A

Solanum lycopersicum

Tomato

Tier IIIUA Flux-Balanced Series

Target Trait

2.7×

fold-change

Umami+Astringency flux-balanced output

Technical Specifications

SKU

SS-F-M2-05551

Genomic Edits

8

GC Content

46.2%

Construct Length

4,300 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

mGluR1 + Polyphenol-astringency axis

IFI Score

270

Pathway Edits

  • mGluR1 pathway primary gene cluster overexpression for umami axis activation
  • Polyphenol-astringency axis pathway primary gene cluster overexpression for astringency axis activation
  • Bidirectional promoter system for synchronized U+A dual-axis co-expression
  • Metabolic flux partitioning between IFI-U and IFI-A pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Umami-Astringency combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for U+A simultaneous accumulation
  • Cofactor balance optimization for U+A dual-pathway operation
  • Protein scaffold engineering for U+A enzyme co-localization

Key Interventions

Dual-receptor co-activation via synchronized mGluR1 and Polyphenol-astringency axis pathway engineeringMetabolic flux partitioning strategy enabling simultaneous umami and astringency accumulation without competing pathway suppressionFlux-balanced gene dosing for UA multi-axis integrationPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier III UA dual-axis flux-balanced platform for food ingredient applications requiring verified combined umami+astringency sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$1499 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities